Tau Biomarker Assays
Alzheimer's disease and other tauopathies
Commercial/DevelopmentActive
Key Facts
Indication
Alzheimer's disease and other tauopathies
Phase
Commercial/Development
Status
Active
Company
About ADx NeuroSciences
ADx NeuroSciences, founded in 2008 and based in Ghent, Belgium, is a specialized diagnostics company developing innovative biomarker assays for neurodegenerative disorders like Alzheimer's, Parkinson's, and Motor Neuron Diseases. Its core capabilities include proprietary antibody generation and the development of robust, fit-for-purpose immunoassays tailored for drug development and clinical research. Operating as a Fujirebio company, ADx serves pharmaceutical clients and technology providers, aiming to improve clinical trial success and patient outcomes through precise biomarker measurement.
View full company profileTherapeutic Areas
Other Alzheimer's disease and other tauopathies Drugs
| Drug | Company | Phase |
|---|---|---|
| Program(s) for Tauopathies | AviadoBio | Pre-clinical |